Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
49.60
-1.02 (-2.02%)
At close: Nov 19, 2026, 4:00 PM EST
49.60
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:15 PM EST
PBH Market Cap
PBH has a market cap or net worth of $2.35 billion as of November 19, 2026. It is the 5,758th most valuable company in the world and the 1,620th biggest in the United States. Its market cap has decreased by 17.38% in one year.
Market Cap
2.35B
Enterprise Value
4.43B
1-Year Change
-17.38%
Global Rank
Country Rank
#1,620 United States
Category
ChartMarket Cap Chart
Since February 10, 2005, PBH's market cap has increased from $887.50M to $2.35B, an increase of 164.89%. That is a compound annual growth rate of 4.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 2.35B | -20.75% |
| Dec 31, 2025 | 2.97B | -23.12% |
| Dec 31, 2024 | 3.86B | 27.01% |
| Dec 29, 2023 | 3.04B | -2.02% |
| Dec 30, 2022 | 3.10B | 2.02% |
| Dec 31, 2021 | 3.04B | 73.93% |
| Dec 31, 2020 | 1.75B | -14.12% |
| Dec 31, 2019 | 2.03B | 27.33% |
| Dec 31, 2018 | 1.60B | -32.17% |
| Dec 29, 2017 | 2.36B | -14.59% |
| Dec 30, 2016 | 2.76B | 1.57% |
| Dec 31, 2015 | 2.72B | 49.91% |
| Dec 31, 2014 | 1.81B | -2.16% |
| Dec 31, 2013 | 1.85B | 83.02% |
| Dec 31, 2012 | 1.01B | 77.97% |
| Dec 30, 2011 | 568.40M | -4.95% |
| Dec 31, 2010 | 598.00M | 52.09% |
| Dec 31, 2009 | 393.20M | -25.36% |
| Dec 31, 2008 | 526.80M | 40.86% |
| Dec 31, 2007 | 374.00M | -42.56% |
| Dec 29, 2006 | 651.10M | 4.09% |
| Dec 30, 2005 | 625.50M | -29.52% |
| Feb 10, 2005 | 887.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 3.54B |
| Bausch Health Companies | 3.17B |
| Xeris Biopharma Holdings | 3.07B |
| HUTCHMED (China) | 2.57B |
| Regencell Bioscience Holdings | 2.26B |
| Perrigo Company | 2.19B |
| Trulieve Cannabis | 1.94B |
| BioCryst Pharmaceuticals | 1.93B |